$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

$sgbx Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000121390021059409 Filed on November 15, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q4
Revenue	$8.453M	$8.847M	$7.350M
YoY Change	15.0%	1434.53%	2061.76%
Cost Of Revenue	$10.28M	$8.742M	$5.750M
YoY Change	78.71%	2188.87%	1882.76%
Gross Profit	-$1.823M	$105.1K	$1.610M
YoY Change	-213.25%	-46.01%	3120.0%
Gross Profit Margin	-21.57%	1.19%	21.9%
Selling, General & Admin	$347.5K	$2.832M	$3.070M
YoY Change	-88.68%	64.63%	184.26%
% of Gross Profit		2695.04%	190.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$145.7K	$96.46K	$90.00K
YoY Change	61.9%	9441.25%	125.0%
% of Gross Profit		91.81%	5.59%
Operating Expenses	$347.5K	$2.832M	$3.070M
YoY Change	-88.68%	64.64%	184.26%
Operating Profit	-$2.171M	-$2.727M	-$1.460M
YoY Change	48.68%	78.76%	41.75%
Interest Expense	$15.70K	$293.00	$20.00K
YoY Change	-21.5%	-88.79%	-111.11%
% of Operating Profit
Other Income/Expense, Net	$1.130K	-$24.05K	$0.00
YoY Change		-151.11%	-100.0%
Pretax Income	-$2.164M	-$2.751M	-$1.440M
YoY Change	50.26%	86.07%	-65.13%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$3.427M	-$3.831M	-$1.630M
YoY Change	110.22%	159.15%	-60.53%
Net Earnings / Revenue	-40.54%	-43.3%	-22.18%
Basic Earnings Per Share		-$0.43
Diluted Earnings Per Share	-$312.5K	-$434.2K	-$188.9K
COMMON SHARES
Basic Shares Outstanding	11.99M shares	8.822M shares	8.596M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.02M	$3.291M	$13.01M
YoY Change	0.11%	-74.78%	698.16%
Cash & Equivalents	$13.02M	$3.291M	$13.01M
Short-Term Investments
Other Short-Term Assets	$3.200M	$20.00M	$570.0K
YoY Change	461.4%	-19.55%	-96.76%
Inventory	$1.274M	$790.1K	$778.1K
Prepaid Expenses
Receivables	$2.918M	$3.567M	$2.636M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$17.91M	$8.949M	$18.30M
YoY Change	-2.1%	-51.94%	529.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.840M	$6.935M	$2.683M
YoY Change	154.94%	300.9%	22739.99%
Goodwill	$1.309M	$1.309M	$1.309M
YoY Change	0.0%	7.01%	7.01%
Intangibles	$2.095M		$2.219M
YoY Change	-5.56%		-3.49%
Long-Term Investments	$3.800M	$3.465M
YoY Change
Other Assets	$112.2K	$122.4K	$150.0K
YoY Change	-25.23%	-23.53%	-21.05%
Total Long-Term Assets	$17.01M	$15.97M	$8.584M
YoY Change	98.16%	107.23%	130.27%
TOTAL ASSETS
Total Short-Term Assets	$17.91M	$8.949M	$18.30M
Total Long-Term Assets	$17.01M	$15.97M	$8.584M
Total Assets	$34.92M	$24.92M	$26.88M
YoY Change	29.92%	-5.34%	305.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.785M	$7.136M	$3.012M
YoY Change	25.64%	258.58%	42.76%
Accrued Expenses	$318.0K	$315.4K	$310.0K
YoY Change	2.57%	1.74%
Deferred Revenue	$1.438M	$1.176M	$1.775M
YoY Change	-19.0%	-58.89%	950.41%
Short-Term Debt	$23.73K	$1.959M	$0.00
YoY Change
Long-Term Debt Due	$19.49K	$19.35K	$20.00K
YoY Change	-2.55%	-3.25%
Total Short-Term Liabilities	$11.59M	$10.84M	$7.235M
YoY Change	60.15%	82.52%	218.08%
LONG-TERM LIABILITIES
Long-Term Debt	$761.6K	$16.57K	$30.00K
YoY Change	2438.8%	-58.58%
Other Long-Term Liabilities	$860.5K	$940.9K	$1.180M
YoY Change	-27.08%	-25.32%
Total Long-Term Liabilities	$1.622M	$957.5K	$1.210M
YoY Change	34.06%	-26.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.59M	$10.84M	$7.235M
Total Long-Term Liabilities	$1.622M	$957.5K	$1.210M
Total Liabilities	$13.21M	$11.80M	$8.444M
YoY Change	56.42%	63.15%	271.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$33.11M	-$29.68M	-$22.28M
YoY Change	48.63%	43.76%	26.69%
Common Stock	$119.9K	$88.23K	$85.96K
YoY Change	39.44%	2.63%	642.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$20.35M	$12.33M	$18.25M
YoY Change
Total Liabilities & Shareholders Equity	$34.92M	$24.92M	$26.88M
YoY Change	29.92%	-5.34%	305.18%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q4
OPERATING ACTIVITIES
Net Income	-$3.427M	-$3.831M	-$1.630M
YoY Change	110.22%	159.15%	-60.53%
Depreciation, Depletion And Amortization	$145.7K	$96.46K	$90.00K
YoY Change	61.9%	9441.25%	125.0%
Cash From Operating Activities	$369.7K	$275.5K	$1.560M
YoY Change	-76.3%	-112.14%	-587.5%
INVESTING ACTIVITIES
Capital Expenditures	-$648.9K	-$113.4K	-$1.520M
YoY Change	-57.31%	126.74%
Acquisitions
YoY Change
Other Investing Activities	-$538.8K	$73.07K	-$90.00K
YoY Change	498.67%	-109.87%
Cash From Investing Activities	-$1.188M	-$40.31K	-$1.610M
YoY Change	-26.23%	-94.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.55M	731.9K	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	369.7K	275.5K	1.560M
Cash From Investing Activities	-1.188M	-40.31K	-1.610M
Cash From Financing Activities	10.55M	731.9K	0.000
Net Change In Cash	9.734M	967.1K	-50.00K
YoY Change	-19567.36%	-131.6%	-103.11%
FREE CASH FLOW
Cash From Operating Activities	$369.7K	$275.5K	$1.560M
Capital Expenditures	-$648.9K	-$113.4K	-$1.520M
Free Cash Flow	$1.019M	$388.9K	$3.080M
YoY Change	-66.93%	-117.52%	-1062.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1012	USD
	sgbx	Sublease Term SubleaseTerm	P1Y
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11201
	dei	City Area Code CityAreaCode	(646)
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001023994
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	484622	USD
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Document Type DocumentType	10-Q
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Entity File Number EntityFileNumber	001-38037
	dei	Entity Registrant Name EntityRegistrantName	SG BLOCKS, INC.
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4463937
	dei	Entity Address Address Line1 EntityAddressAddressLine1	195 Montague Street,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	14th Floor,
	dei	Entity Address City Or Town EntityAddressCityOrTown	Brooklyn
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3566616	USD
	dei	Local Phone Number LocalPhoneNumber	240-4235
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	SGBX
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11986873	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3290702	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13010356	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2635608	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1303136	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	790081	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	778144	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	816761	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	570775	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	8948782	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	18298019	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6935265	USD
CY2021Q3	us-gaap	Goodwill Goodwill	1309330	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1309330	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1292803	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1537545	USD
CY2021Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	710685	USD
CY2020Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	682637	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2218609	USD
CY2021Q3	us-gaap	Deferred Costs DeferredCosts	122355	USD
CY2020Q4	us-gaap	Deferred Costs DeferredCosts	152944	USD
CY2021Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3464762	USD
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures		USD
CY2021Q3	us-gaap	Assets Assets	24921038	USD
CY2020Q4	us-gaap	Assets Assets	26882098	USD
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7135750	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3961961	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1176180	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1774740	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	334736	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	326654	USD
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	232110	USD
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	965561	USD
CY2021Q3	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	5795	USD
CY2020Q4	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	200765	USD
CY2021Q3	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1959018	USD
CY2020Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable		USD
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	10843589	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7234681	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	957497	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1209594	USD
CY2021Q3	us-gaap	Liabilities Liabilities	11801086	USD
CY2020Q4	us-gaap	Liabilities Liabilities	8444275	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8822489	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8822489	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8596189	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8596189	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	88225	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	85962	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	41927422	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40443840	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29682587	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22276546	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	12333060	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	18253256	USD
CY2021Q3	us-gaap	Minority Interest MinorityInterest	786892	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	184567	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13119952	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18437823	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24921038	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26882098	USD
CY2021Q3	us-gaap	Revenues Revenues	8847490	USD
CY2020Q3	us-gaap	Revenues Revenues	576560	USD
	us-gaap	Revenues Revenues	29889104	USD
	us-gaap	Revenues Revenues	1404265	USD
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	8742420	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	381954	USD
	us-gaap	Cost Of Revenue CostOfRevenue	25736809	USD
	us-gaap	Cost Of Revenue CostOfRevenue	789445	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	105070	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	194606	USD
	us-gaap	Gross Profit GrossProfit	4152295	USD
	us-gaap	Gross Profit GrossProfit	614820	USD
CY2021Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1236420	USD
CY2020Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	679863	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2865606	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1344009	USD
CY2020Q3	us-gaap	Other General Expense OtherGeneralExpense	12650	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-34182	USD
CY2021Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1517718	USD
CY2020Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	980773	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	4867236	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2238837	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	46650	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	197922	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	109887	USD
CY2021Q3	us-gaap	Other General Expense OtherGeneralExpense	22683	USD
	us-gaap	Other General Expense OtherGeneralExpense	33663	USD
	us-gaap	Other General Expense OtherGeneralExpense	37650	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	2831678	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	1719936	USD
	us-gaap	Operating Expenses OperatingExpenses	7964427	USD
	us-gaap	Operating Expenses OperatingExpenses	3730383	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2726608	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1525330	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3812132	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3115563	USD
CY2021Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-34182	USD
CY2020Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1012	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	293	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	2614	USD
	us-gaap	Interest Expense InterestExpense	985	USD
	us-gaap	Interest Expense InterestExpense	8877	USD
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	9973	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	27401	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	41240	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	38497	USD
CY2021Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	453	USD
CY2020Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	23282	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	61477	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	23282	USD
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24049	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	47057	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	67550	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	51890	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2750657	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1478273	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3744582	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3063673	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-2750657	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-1478273	USD
	us-gaap	Profit Loss ProfitLoss	-3744582	USD
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1080248	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3661459	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3830905	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1478273	USD
	us-gaap	Net Income Loss NetIncomeLoss	-7406041	USD
	us-gaap	Net Income Loss NetIncomeLoss	-3063673	USD
CY2021Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.43
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.84
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.60
CY2021Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8822489	shares
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8596189	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8796890	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5070816	shares
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16840723	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	246236	USD
CY2021Q3	sgbx	Noncontrollinginterestdistribution Noncontrollinginterestdistribution	-1216350	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-2750657	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13119952	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18437823	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	778657	USD
	sgbx	Stock Issued During Period Value Conversion Of Unit StockIssuedDuringPeriodValueConversionOfUnit	707188	USD
	sgbx	Noncontrollinginterestdistribution Noncontrollinginterestdistribution		USD
	us-gaap	Profit Loss ProfitLoss	-3744582	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13119952	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20267884	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	303169	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	471683	USD
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		USD
	sgbx	Stock Issued During Period Values Reverse Stock Splits StockIssuedDuringPeriodValuesReverseStockSplits	-122	USD
	sgbx	Conversion Of Debt Exchange Value ConversionOfDebtExchangeValue	206263	USD
	sgbx	Stock Issued During Period Issuance Of Common Stock Net Of Issuance Costs StockIssuedDuringPeriodIssuanceOfCommonStockNetOfIssuanceCosts	17118480	USD
	us-gaap	Profit Loss ProfitLoss	-3063673	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19092780	USD
	us-gaap	Profit Loss ProfitLoss	-3744582	USD
	us-gaap	Profit Loss ProfitLoss	-3063673	USD
	us-gaap	Depreciation Depreciation	2858	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	124053	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	108842	USD
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	30589	USD
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	30590	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	161202	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	28048	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	23185	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	778657	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	471683	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-34182	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1012	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1092210	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2581925	USD
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-818514	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11937	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	681521	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	235202	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	189143	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-390581	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3173788	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-841778	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-598560	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2322164	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-738451	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	5000	USD
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-389853	USD
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1032417	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4453862	USD
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		USD
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	650000	USD
	sgbx	Proceeds From Acquisition ProceedsFromAcquisition		USD
	sgbx	Proceeds From Acquisition ProceedsFromAcquisition	743168	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4806294	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49434	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	42500	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	225000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	194969	USD
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition		USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3464762	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8283525	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1442602	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	707188	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	17118480	USD
	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	1948234	USD
	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt		USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	200000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	3059134	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders		USD
	sgbx	Settlement Of Common Stock From Reverse Stock Split SettlementOfCommonStockFromReverseStockSplit	122	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-403712	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17318358	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-9719654	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11421894	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13010356	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1625671	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3290702	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13047565	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	200000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1		USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	6263	USD
	sgbx	Non Cash Operating Activities NonCashOperatingActivities		USD
	sgbx	Non Cash Operating Activities NonCashOperatingActivities	206263	USD
CY2020Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-20
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8822489	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8822489	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3290702	USD
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	20000000	USD
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	20074693	USD
CY2020Q2	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	1522339	USD
CY2020Q2	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	15596141	USD
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	10520000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div> <div> <p style="color: #000000; font: 10pt 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0pt 0px 0pt 0.5in;"><span style="color: black;"><span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-right: none; border-left: none; line-height: inherit;"><b><i>Accounting estimates<span style="line-height: inherit;"> </span></i></b>– The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Significant areas that require the Company to make estimates include revenue recognition, stock-based compensation, stock warrants liabilities and allowance for credit losses. Actual results could differ from those estimates.</span></span></span></p> </div> </div> </div> </div> </div> </div>
	sgbx	No Of Operating Cycles NoOfOperatingCycles	one year
	sgbx	Termofagreement Termofagreement	P2Y
	us-gaap	Restricted Cash And Cash Equivalent Item Description RestrictedCashAndCashEquivalentItemDescription	Under the Agreement, the Company had a right of first refusal with respect to being engaged as a designer and builder of any real estate projects for which CMC has secured the rights to develop and in which CMC has a greater than fifty percent (50%) interest in the owner or developer entity and has the right to select the builder for such real estate project (the “ROFR Rights”). In exchange for such ROFR Rights, the Company agreed to issue to CMC 2,500 shares of restricted stock of the Company’s common stock, of which 1,250 shares vested on March 31, 2021 and the remaining 1,250 shares was to vest and be issued on September 30, 2021, unless the Agreement is earlier terminated. In the event that the Agreement was earlier terminated, CMC was entitled to receive the entire amount of such restricted stock that had vested as of such earlier termination date, but in no event less than 1,250 shares of such restricted stock. The Agreement also provided for customary indemnification and confidentiality obligations between the parties. The 2,500 shares of restricted stock of the Company's common stock has yet to be issued to CMC.
	sgbx	Total Expected Gross Revenue TotalExpectedGrossRevenue	16900000	USD
	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	5983027	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	576560	USD
CY2020Q3	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8847490	USD
CY2021Q3	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	576560	USD
CY2020Q3	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29889104	USD
	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1404265	USD
	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2021Q3	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	102217	USD
CY2021Q3	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	203926	USD
CY2021Q3	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	81570	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	30589	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	30589	USD
	sgbx	License Consideration Description LicenseConsiderationDescription	In consideration for the License, during the initial term, the Licensee agreed to pay the Company a royalty of (x) five percent (5%) on the first $20,000,000 of gross revenues derived from the Licensee’s commercialization of the License (net of customary discounts, sales taxes, delivery charges, and amounts for returns) (the “Gross Revenues”), (y) four and one-half percent (4.5%) on the next $30,000,000 of Gross Revenues, and (z) five percent (5%) on all Gross Revenues thereafter (collectively, the “Royalty”)
	sgbx	Minimum Royalty Payments One Year MinimumRoyaltyPaymentsOneYear	500000	USD
	sgbx	Minimum Royalty Payments Two Year MinimumRoyaltyPaymentsTwoYear	750000	USD
	sgbx	Minimum Royalty Payments Three Year MinimumRoyaltyPaymentsThreeYear	1500000	USD
	sgbx	Minimum Royalty Payments Four Year MinimumRoyaltyPaymentsFourYear	2000000	USD
	sgbx	Minimum Royalty Payments Five Year MinimumRoyaltyPaymentsFiveYear	2500000	USD
	sgbx	Redemption Distributions RedemptionDistributions	1250000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	232110	USD
	us-gaap	Other Income OtherIncome	60000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3290702	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13010356	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2021Q3	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2021Q3	sgbx	Medicalequipment Medicalequipment	790081	USD
	us-gaap	Impaired Intangible Asset Description ImpairedIntangibleAssetDescription	Intangible assets consist of $2,766,000 of proprietary knowledge and technology, which is being amortized over 20 years. In addition, $97,164 of trademarks, and $47,800 of website costs are being amortized over 5 years.
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	773908	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	610157	USD
	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	41823	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	162970	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	161176	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	160469	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	157051	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1453567	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2137056	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">–</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any significant credit risk on the account.</span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span>With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At September 30, 2021 and December 31, 2020, 62% and 79%, respectively, of the Company’s gross accounts receivable in excess of 10% were due from <span>two</span> and three customers. </span></p> <p style="margin: 0pt; text-indent: 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span>Revenue in excess of 10% relating to one and four customers represented approximately 90% and 83% of the Company's total revenue for the three months ended September 30, 2021 and 2020, respectively. <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">Revenue relating to <span style="border-left: none; border-right: none;"><span style="border-right: none; border-left: none;">one</span></span></span><span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"> and </span><span>three</span><span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"> customers represented approximately 77</span><span>% and 53%</span></span><span style="font-family: 'Times New Roman'; font-size: 13.3333px; float: none; display: inline !important;"> of the Company's total revenue for the </span>nine months ended September 30, 2021<span style="font-family: 'Times New Roman'; font-size: 13.3333px; float: none; display: inline !important;"> and </span><span>2020</span><span style="font-family: 'Times New Roman'; font-size: 13.3333px; float: none; display: inline !important;">, respectively.</span></p> <p style="margin: 0pt; text-indent: 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span><span>Cost of revenue in excess of 10% relating to three and two </span>vendors represented approximately 68% and 63% of the Company’s total cost of revenue for the three months ended September 30, 2021 and 2020, respectively. Cost of revenue relating to four and <span>four</span> <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">vendors represented approximately 54</span><span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">% and </span><span>67</span><span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">% of the Company’s total cost of revenue for the nine months ended </span>September 30, 2021<span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"> and </span><span>2020</span><span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">, respectively. </span>The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers.</span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span><br/></span></p>
CY2021Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4523732	USD
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3431522	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	957116	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	795914	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3566616	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2635608	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	957116	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	795914	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	161202	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10018	USD
CY2021Q3	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	8670563	USD
CY2020Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	4572581	USD
CY2021Q3	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts	1321094	USD
CY2020Q4	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts		USD
CY2021Q3	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-3584557	USD
CY2020Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	872302	USD
CY2021Q3	sgbx	Contract Assets Gross ContractAssetsGross	6407100	USD
CY2020Q4	sgbx	Contract Assets Gross ContractAssetsGross	5444883	USD
CY2020Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	5916487	USD
CY2021Q3	sgbx	Netcontractliabilitiesonuncompletedcontracts Netcontractliabilitiesonuncompletedcontracts	-691558	USD
CY2020Q4	sgbx	Netcontractliabilitiesonuncompletedcontracts Netcontractliabilitiesonuncompletedcontracts	-471604	USD
CY2021Q3	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent	484622	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1176180	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1774740	USD
CY2021Q3	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-691558	USD
CY2020Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-471604	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7242885	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2741514	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	307620	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	58500	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6935265	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2683014	USD
CY2021Q3	us-gaap	Depreciation Depreciation	96462	USD
	us-gaap	Depreciation Depreciation	294860	USD
	us-gaap	Depreciation Depreciation	2858	USD
CY2021Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2000000	USD
CY2021Q3	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	1948234	USD
CY2021Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
CY2021Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.12	pure
CY2021Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.005	pure
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	52347	USD
CY2021Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	52347	USD
CY2020Q3	sgbx	Acquisition Cash AcquisitionCash	1059600	USD
CY2021Q3	us-gaap	Cash Cash	1059600	USD
CY2021Q3	sgbx	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Earnoutliability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEarnoutliability		USD
CY2021Q3	sgbx	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Settlement Of Accounts Receivable And Net Contract Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSettlementOfAccountsReceivableAndNetContractLiabilities	-94980	USD
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	964620	USD
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	316432	USD
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	252557	USD
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	130799	USD
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	7400	USD
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	1154818	USD
CY2021Q3	sgbx	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Rightofuseassets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightofuseassets	57120	USD
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Less Noncontrolling Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest	85810	USD
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	68344	USD
CY2021Q3	sgbx	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accounts Payable And Accrued Expenses BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses	733529	USD
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	285204	USD
CY2021Q3	sgbx	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contractliabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractliabilities	32807	USD
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Capital Lease Obligation BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation	57120	USD
CY2021Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	964620	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The leases have remaining lease terms of two and a half years to five years. The plant lease includes an option to extend the lease for up to five years.
CY2021Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P18M
CY2021Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	35918	USD
CY2021Q3	sgbx	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	1255803	USD
CY2021Q3	sgbx	Operating Lease Liabilities Current OperatingLeaseLiabilitiesCurrent	315389	USD
CY2021Q3	sgbx	Operating Lease Liabilities Noncurrent OperatingLeaseLiabilitiesNoncurrent	940926	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1256315	USD
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	37000	USD
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	19347	USD
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	16571	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M4D
CY2021Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y10M9D
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2021Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	87085	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	5040	USD
CY2021Q3	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	92125	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	348984	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	20160	USD
CY2021Q3	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	369144	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	330300	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	11760	USD
CY2021Q3	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	342060	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	324000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		USD
CY2021Q3	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	324000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	243000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive		USD
CY2021Q3	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	243000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1333369	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	36960	USD
CY2021Q3	us-gaap	Other Commitment OtherCommitment	1370329	USD
CY2021Q3	sgbx	Total Operating Imputed Interest TotalOperatingImputedInterest	77054	USD
CY2021Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	1042	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	78096	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1256315	USD
CY2021Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	35918	USD
CY2021Q3	sgbx	Presentvalueofleaseliabilities Presentvalueofleaseliabilities	1292233	USD
	sgbx	Contract Revenue ContractRevenue	6306215	USD
CY2021Q3	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	20074693	USD
CY2020Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	25117461	USD
CY2019Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	17634261	USD
	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	2335996	USD
	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	13816785	USD
	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	-1395737	USD
	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	-27370	USD
	sgbx	Construction Backlog Gross ConstructionBacklogGross	26057720	USD
	sgbx	Construction Backlog Gross ConstructionBacklogGross	31423676	USD
	sgbx	Contract Revenue ContractRevenue	5983027	USD
CY2020Q3	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	25117461	USD
	sgbx	Contract Backlog Description ContractBacklogDescription	two contracts entered into during the third quarter of 2020 in the amount of approximately $4 million and approximately $2.95 million
CY2021Q1	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	1300000	USD
CY2021Q3	sgbx	Cancellation Of Construction Backlog Contract Amountbacklogcontract CancellationOfConstructionBacklogContractAmountbacklogcontract	1300000	USD
	sgbx	Redemption Distribution Amount RedemptionDistributionAmount	1250000	USD
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	20074693	USD
CY2020Q2	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	1522339	USD
CY2020Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	347661	USD
CY2020Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6000000	shares
CY2020Q2	sgbx	Options Granted To Purchase Common Stock OptionsGrantedToPurchaseCommonStock	900000	shares
CY2020Q2	sgbx	Common Stock Exercise Price Per Share CommonStockExercisePricePerShare	0.01
CY2020Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	900000	shares
CY2020Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6900000	shares
CY2020Q2	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	15596141	USD
CY2020Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1653859	USD
CY2020Q2	sgbx	Common Stock Number Of Shares Underwritter CommonStockNumberOfSharesUnderwritter	300000	shares
CY2017Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-06-21
CY2020Q2	sgbx	Warrants To Purchase WarrantsToPurchase	300000	shares
	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P5Y7M2D
CY2021Q3	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne		USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	36332	shares
CY2020Q2	us-gaap	Share Price SharePrice	3.14
CY2020Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-05-05
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	226300	shares
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	707000	USD
CY2019Q4	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	15000	USD
CY2019Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5404	shares
CY2019Q4	sgbx	Exercise Price Perentage ExercisePricePerentage	1.10	pure
CY2019Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2019Q4	sgbx	Common Stock Shares Purchased CommonStockSharesPurchased	5404	shares
CY2016Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3625000	shares
CY2021Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2679547	shares
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	246236	USD
CY2020Q3	us-gaap	Share Based Compensation ShareBasedCompensation	303169	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	778657	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	471683	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36437	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	35.54
CY2020Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	78.71
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y4M2D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36437	shares
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.80
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	78.71
CY2020Q4	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.80
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	78.67
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y4M2D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		USD
CY2021Q3	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.80
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	78.71
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y7M2D
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		USD
CY2021Q3	us-gaap	Share Price SharePrice	3.27
CY2019Q1	sgbx	Number Of Consultants NumberOfConsultants	1	Consultants
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	Restricted stock units granted to Mr. Galvin, Mr. Armstrong, Mr. Shetty, and an aggregate of six employees and one consultant of 6,139, 772, 5,729 and an aggregate of 3,063, respectively, vest in installments over either a one-year, two-year, three-year and four-year period and will fully vest by the end of December 31, 2022. The fair value of these units upon issuance amounted to $847,957.
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	a total of 526 of restricted stock units were granted to two of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $58.80 and $55.20 per share, respectively, which represents the average closing price of the Company’s common stock for the ten trading days immediately preceding and including the grant date, as adjusted for stock splits.
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	a total of 526 of restricted stock units were granted to two of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $58.80 and $55.20 per share, respectively, which represents the average closing price of the Company’s common stock for the ten trading days immediately preceding and including the grant date, as adjusted for stock splits.
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	527504	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	172998	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	354506	shares
CY2020Q1	sgbx	Unpaid Wages UnpaidWages	372638	USD
CY2020Q1	sgbx	Severance Amount SeveranceAmount	300000	USD
CY2020Q2	sgbx	Severance Amount SeveranceAmount	300000	USD
CY2021Q3	us-gaap	Litigation Reserve LitigationReserve	278800	USD

Files In Submission

Name	View Source	Status
0001213900-21-059409-index-headers.html	Edgar Link	pending
0001213900-21-059409-index.html	Edgar Link	pending
0001213900-21-059409.txt	Edgar Link	pending
0001213900-21-059409-xbrl.zip	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgbx-20210930.htm	Edgar Link	pending
sgbx-20210930.xsd	Edgar Link	pending
sgbx-20210930_cal.xml	Edgar Link	unprocessable
sgbx-20210930_def.xml	Edgar Link	unprocessable
sgbx-20210930_htm.xml	Edgar Link	completed
sgbx-20210930_lab.xml	Edgar Link	unprocessable
sgbx-20210930_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2021 Q4 Form 10-Q Financial Statement

#000121390021059409 Filed on November 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2021 Q4 Form 10-Q Financial Statement

#000121390021059409 Filed on November 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx